Filling the need for trusted information on national health issues…

Treatment Cost Savings Under PEPFAR Can Be Re-Invested To Increase ARV Reach

In this post in the “Health Affairs Blog,” Matthew Kavanagh, director of U.S. policy and advocacy at Health Global Access Project (GAP), and Marguerite Thorp, a research assistant at Harvard Medical School, examine how HIV/AIDS treatment funding under PEPFAR has “fallen significantly since 2008 in both absolute dollars and as a portion of total budgets — just at a pivotal moment when investment could change the course of the epidemic.” They say that cost-savings due to declining antiretroviral (ARV) drug prices and efficiencies in programs have allowed PEPFAR to continue to scale up the number of people receiving treatment with a shrinking budget, and argue that those cost savings should be re-invested in ARV treatment programs to boost the number of “treatment slots” even higher (11/29).

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.